StockData

Intercure Ltd. (INCR) KPIs and segments

INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.63−0.16 (-4.22%)

Close on Nov 16, 2026Market cap $198.49MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Intercure's business

Intercure's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q4 2025
Q4 2024
Q4 2023
Q4 2022
Q4 2021
Q4 2020
Q4 2019
Cannabis segment(₪M)
69076075588655111547.8
Biomed segment(₪M)
0.212.402.062.772.903.5240.1

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-04-30.

See a number that looks wrong?